NCT02895789
- Conditions
- Behavior, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Columbia University Medical Center New York, United States
Clinical trial condition
Spinal Muscular Atrophy Type 3
Explore clinical trials studying Spinal Muscular Atrophy Type 3. Study availability and eligibility vary by location and protocol.
14 public trials
4 recruiting studies
Spinal Muscular Atrophy Type 3 trial results
Active, Not Recruiting
Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb
NCT06300996
- Conditions
- Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +14 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855
- Conditions
- Anti-myostatin, Atrophy, Central Nervous System Diseases, +20 more
- Locations
-
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- UCSD Altman Clinical and Translational Research La Jolla, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Stanford Neuroscience Health Center Palo Alto, California, United States
Active, Not Recruiting
Spinraza in Adult Spinal Muscular Atrophy
NCT03709784
- Conditions
- Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +11 more
- Locations
-
- Barrow Neurological Institute Phoenix, Arizona, United States
- Georgetown University Washington D.C., District of Columbia, United States
- Johns Hopkins Baltimore, Maryland, United States
- Massachusetts General Hospital-Harvard University Boston, Massachusetts, United States